Get the Stockscreener App
1.68
2.61%
-0.045
Seer Inc stock is traded at $1.68, with a volume of 263.20K.
It is down -2.61% in the last 24 hours and down -15.15% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.725
Open:
$1.73
24h Volume:
263.20K
Relative Volume:
0.98
Market Cap:
$94.79M
Revenue:
$16.45M
Net Income/Loss:
$-73.60M
P/E Ratio:
-1.313
EPS:
-1.2795
Net Cash Flow:
$-46.25M
1W Performance:
-7.18%
1M Performance:
-15.15%
6M Performance:
-24.66%
1Y Performance:
-11.58%
1-Day Range:
$1.68
$1.73
1-Week Range:
$1.68
$1.84
52-Week Range:
$1.62
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ALNY, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.68 | 94.79M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
454.00 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
732.87 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.17 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
663.93 | 41.09B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
275.28 | 30.56B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer (NASDAQ:SEER) Shares Down 2.6%Here's What Happened - MarketBeat
SEER Should I Buy - Intellectia AI
SEER.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SEER.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SEER.O Technical Analysis & Stock Price Forecast - Intellectia AI
Retail Trends: What is the target price for Seer Inc stockProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn
Seer Inc stock (ISIN: US8158581079) gains traction as protein-analysis platform expands clinical ado - AD HOC NEWS
Seer, Inc. Announces Amendment No. 1 to Tax Benefit Preservation Plan in Latest 8-K Filing - Minichart
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit - Investing.com India
Seer Amends Tax Benefit Plan After Stockholder Challenge - TipRanks
Seer (NASDAQ: SEER) updates tax benefit plan after Delaware action - Stock Titan
Aug PostEarnings: Will Seer Inc stock recover after earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Setup Watch: What is the target price for Seer Inc stock2025 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
Aug Sectors: Is now the right time to enter Seer IncWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Sentiment Watch: Whats the fair value of AEV CL stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Sectors Review: Can Seer Inc be recession proof2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Aug Volume: What is the target price for Seer Inc stockEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
SEER: Strong growth, innovation, and new detector tech set the stage for future expansion - TradingView
Bradley Radoff Sends Open Letter to Seer, Inc. - marketscreener.com
Seer (SEER) Stockholders Express Concerns Over Management and Fi - GuruFocus
Incorrect alert on Seer Inc's forecast withdrawn - marketscreener.com
Radoff-Jec Group calls on Seer board to announce sale process - marketscreener.com
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs - Stock Titan
SEER Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activist group in Seer (SEER) reports 7.6% stake and opposes NOL pill - Stock Titan
Seer (NASDAQ: SEER) expands Proteograph platform and targets $30B proteomics market - Stock Titan
Seer 10-K: Revenue $16.58M, EPS $(1.28) - TradingView
Seer Inc. Balances Growth Momentum With Cautious Outlook - The Globe and Mail
Seer, Inc. (NASDAQ:SEER) Q4 2025 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Seer Q4 Earnings Call Highlights - Yahoo Finance
Seer, Inc. (NASDAQ:SEER) Short Interest Up 126.6% in February - MarketBeat
Seer Inc (SEER) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Funding Challenges - GuruFocus
SEER Technical Analysis & Stock Price Forecast - Intellectia AI
Seer, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-02-27 - Seeking Alpha
Seer (SEER) Q4 2025 Earnings Call Transcript - AOL.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Seer Adopts Tax Benefit Plan to Protect NOLs - TipRanks
Seer Inc. (NASDAQ:SEER) Shares Plunge on Weak 2026 Revenue Guidance - ChartMill
SEER: 2025 revenue rose 17% to $16.6M, but 2026 growth is tempered by funding headwinds - TradingView
Seer (NASDAQ:SEER) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Earnings call transcript: Seer Inc. reports Q4 2025 earnings beat, stock dips - Investing.com Australia
SEER: 2025 revenue rose 17% to $16.6M, but 2026 guidance remains cautious amid funding uncertainty - TradingView
Q4 2025 Seer Inc Earnings Call Transcript - GuruFocus
Seer Q4 Earnings Summary & Key Takeaways - Benzinga
Seer, Inc. Adopts Tax Benefit Preservation Plan to Protect Income Tax Net Operating Losses - Quiver Quantitative
Seer (SEER) sets 4.9% tax benefit rights plan with $11 exercise price - Stock Titan
SEER: 2025 revenue rose 17% year-over-year, with improved margins and a strong liquidity position - TradingView
[8-K] Seer, Inc. Reports Material Event | SEER SEC FilingForm 8-K - Stock Titan
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook - marketscreener.com
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets - marketscreener.com
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):